z-logo
open-access-imgOpen Access
Evaluation of the Immunogenicity and Biological Activity of the Citrobacter freundii Vi-CRM 197 Conjugate as a Vaccine for Salmonella enterica Serovar Typhi
Author(s) -
Simona Rondini,
Francesca Micoli,
Luisa Lanzilao,
Christine Hale,
Allan Saul,
Laura B. Martin
Publication year - 2011
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00387-10
Subject(s) - citrobacter freundii , immunogenicity , salmonella enterica , serotype , microbiology and biotechnology , conjugate , salmonella typhi , virology , salmonella , citrobacter , enterobacteriaceae , biology , antigen , bacteria , escherichia coli , immunology , genetics , gene , mathematical analysis , mathematics
Typhoid fever remains a major health problem in developing countries. Young children are at high risk, and a vaccine effective for this age group is urgently needed. Purified capsular polysaccharide fromSalmonella enterica serovar Typhi (Vi) is licensed as a vaccine, providing 50 to 70% protection in individuals older than 5 years. However, this vaccine is ineffective in infants. Vi conjugated to a carrier protein (i.e., an exoprotein A mutant fromPseudomonas aeruginosa [rEPA]) is highly immunogenic, provides long-term protection, and shows more than 90% protective efficacy in children 2 to 5 years old. Here, we describe an alternative glycoconjugate vaccine forS . Typhi, Vi-CRM197 , where Vi was obtained fromCitrobacter freundii WR7011 and CRM197 , the mutant diphtheria toxin protein, was used as the carrier. We investigated the optimization of growth conditions for Vi production fromC. freundii WR7011 and the immunogenicity of Vi-CRM197 conjugates in mice. The optimal saccharide/protein ratio of the glycoconjugates was identified for the best antibody production. We also demonstrated the ability of this new vaccine to protect mice against challenge with Vi-positiveSalmonella enterica serovar Typhimurium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here